Published:
May 13, 2021
Last Updated:
May 13, 2021
Services:
Chemicals More...
Priorities:
Achieving Sustainability More...
Topics:
Fermentation-Derived Protein | Plant Protein More...
Activities:
Other financial
Further Reading
G2 Venture closes $500 million fund targeting climate change-mitigating technologies but still lacks deep decarbonization startups
News Commentary | July 08, 2021
Last month, G2V announced the close of a $500 million fund following its inaugural $350 million fund in 2017. Continuing with its original investment thesis, G2V will target companies active in the energy, manufacturing, logistics, transportation, and agriculture industries, with an emphasis on "... Not part of subscription
Funding momentum for cell-based meat continues as Aleph Farms raises $105 million Series B
News Commentary | July 08, 2021
L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription
Impossible Foods completes $500 million funding round, signaling continued growth for plant-based meat
News Commentary | November 26, 2021
Impossible Foods has completed a $500 million funding round, led by Mirae Asset Global Investments, which makes Impossible the best‑funded and highest‑valued U.S. startup in plant‑based meat. The company has raised over $2 billion since 2011 and is reportedly eyeing a $10 billion initial public ... Not part of subscription
by Kristin Marshall and Harini Venkataraman
Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre-money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO announcement, through which it raised $500 million. While the two have significantly evolved over the years, in Ginkgo's case, the company has further diversified through different spinouts targeting ag biologicals, alternative protein ingredients, and bioremediation. Clients should note that Ginkgo is playing a numbers game – it does not depend on any one project to succeed. Additional funding will only expand its reach and disruption potential.
For the original news article, click here .